Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

References

• Wang TX, Tan WL, Huang JC, et al. Identification of aberrantly methylated differentially expressed genes targeted by differentially expressed miRNA in osteosarcoma. Ann Transl Med. 2020;8(6):373.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu G, Wu Y, et al. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling. Mol Cancer. 2019;18(1):150.
   PubMed Web of Science ®Google Scholar
• Jiang N, Wang X, Xie X, et al. lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 2017;405:46–55.
   PubMed Web of Science ®Google Scholar
• Wang X, Qin G, Liang X, et al. Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma. Nat Commun. 2020;11(1):1141.
   PubMed Web of Science ®Google Scholar
• De I, Sadhukhan S. Emerging roles of DHHC-mediated protein S-palmitoylation in physiological and pathophysiological context. Eur J Cell Biol. 2018;97(5):319–338.
   PubMed Web of Science ®Google Scholar
• Gottlieb CD, Linder ME. Structure and function of DHHC protein S-acyltransferases. Biochem Soc Trans. 2017;45(4):923–928.
   PubMed Web of Science ®Google Scholar
• Chen X, Hu L, Yang H, et al. DHHC protein family targets different subsets of glioma stem cells in specific niches. J Exp Clin Cancer Res. 2019;38(1):25.
   PubMedGoogle Scholar
• Niu J, Sun Y, Chen B, et al. Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation. Nature. 2019;573(7772):139–143.
   PubMed Web of Science ®Google Scholar
• Lai X, Eberhardt M, Schmitz U, et al. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. Nucleic Acids Res. 2019;47(15):7753–7766.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang C, Yu T, et al. MicroRNAs control mRNA fate by compartmentalization based on 3’ UTR length in male germ cells. Genome Biol. 2017;18(1):105.
   PubMedGoogle Scholar
• Allen L, Dwivedi Y. MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior. Mol Psychiatry. 2020;25(2):308–320.
   PubMed Web of Science ®Google Scholar
• Wei L, Wang X, Lv L, et al. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer. 2019;18(1):147.
   PubMed Web of Science ®Google Scholar
• Leonetti A, Assaraf YG, Veltsista PD, et al. MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions. Drug Resist Updates. 2019;42:1–11.
   PubMed Web of Science ®Google Scholar
• Rajendiran S, Parwani AV, Hare RJ, et al. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1. Mol Cancer. 2014;13(1):250.
   PubMedGoogle Scholar
• Song B, Zhang C, Li G, et al. MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88. Cell Physiol Biochem. 2015;35(3):1167–1177.
   PubMedGoogle Scholar
• Zhao J, Hou Y, Yin C, et al. Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma. Oncogene. 2020;39(8):1724–1738.
   PubMed Web of Science ®Google Scholar
• Lin ZW, Zhang W, Jiang SD, et al. Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/β-catenin signaling pathway. J Cell Biochem. 2018. DOI:10.1002/jcb.27580
   Web of Science ®Google Scholar
• Chen J, Yu Y, Li H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18(1):33.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang Q, Wang L, et al. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma. Cell Death Dis. 2018;9(6):627.
   PubMedGoogle Scholar
• Yu Y, Zhao D, Li K, et al. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway. Cell Death Dis. 2020;11(4):273.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu L, Dong Z, et al. Expression patterns and prognostic value of m(6)A-related genes in colorectal cancer. Am J Transl Res. 2019;11(7):3972–3991.
   PubMed Web of Science ®Google Scholar
• Wu CC, Beird HC, Andrew Livingston J, et al. Immuno-genomic landscape of osteosarcoma. Nat Commun. 2020;11(1):1008.
   PubMed Web of Science ®Google Scholar
• Dzikiewicz-Krawczyk A, Kok K, Slezak-Prochazka I, et al. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma. Leukemia. 2017;31(6):1470–1473.
   PubMed Web of Science ®Google Scholar
• Chen X, Hao A, Li X, et al. Activation of JNK and p38 MAPK mediated by ZDHHC17 drives glioblastoma multiforme development and malignant progression. Theranostics. 2020;10(3):998–1015.
   PubMed Web of Science ®Google Scholar
• Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19(10). DOI:10.15252/embr.201846666
   PubMed Web of Science ®Google Scholar
• Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126–132.
   PubMed Web of Science ®Google Scholar
• Xu XZ, Song H, Zhao Y, et al. MiR-654-5p regulated cell progression and tumor growth through targeting SIRT6 in osteosarcoma. Eur Rev Med Pharmacol Sci. 2020;24(7):3517–3525.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wei L, Sheng W, et al. miR-1225-5p functions as a tumor suppressor in osteosarcoma by targeting Sox9. DNA Cell Biol. 2020;39(1):78–91.
   PubMed Web of Science ®Google Scholar
• Luo H, Xu R, Chen B, et al. MicroRNA-940 inhibits glioma cells proliferation and cell cycle progression by targeting CKS1. Am J Transl Res. 2019;11(8):4851–4865.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao M, Zhao H, et al. MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer. Onco Targets Ther. 2019;12:2809–2822.
   PubMed Web of Science ®Google Scholar
• Xu T, Zhang K, Shi J, et al. MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2. Am J Cancer Res. 2019;9(2):250–269.
   PubMed Web of Science ®Google Scholar
• Li P, Xiao Z, Luo J, et al. MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1. J Cell Mol Med. 2019;23(4):2475–2488.
   PubMed Web of Science ®Google Scholar
• Xiao X, Zhang Y, Lin Q, et al. The better effects of microbubble ultrasound transfection of miR-940 on cell proliferation inhibition and apoptosis promotion in human cervical cancer cells. Onco Targets Ther. 2019;12:6813–6824.
   PubMed Web of Science ®Google Scholar
• Jiang K, Zhao T, Shen M, et al. MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting snail in non-small cell lung cancer. J Cancer. 2019;10(12):2735–2744.
   PubMed Web of Science ®Google Scholar
• Ding D, Zhang Y, Yang R, et al. miR-940 suppresses tumor cell invasion and migration via regulation of CXCR2 in hepatocellular carcinoma. Biomed Res Int. 2016;2016:7618342.
   PubMed Web of Science ®Google Scholar
• Wang H, Song T, Qiao Y, et al. miR-940 inhibits cell proliferation and promotes apoptosis in esophageal squamous cell carcinoma cells and is associated with post-operative prognosis. Exp Ther Med. 2020;19(2):833–840.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Z, Gu X, et al. miR-940 upregulation suppresses cell proliferation and induces apoptosis by targeting PKC-δ in ovarian cancer OVCAR3 cells. Oncol Res. 2017;25(1):107–114.
   PubMed Web of Science ®Google Scholar